Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks
- PMID: 39333526
- PMCID: PMC11436835
- DOI: 10.1038/s41467-024-52622-w
Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks
Erratum in
-
Author Correction: Predicting standardized uptake value of brown adipose tissue from CT scans using convolutional neural networks.Nat Commun. 2024 Nov 19;15(1):10022. doi: 10.1038/s41467-024-54209-x. Nat Commun. 2024. PMID: 39562561 Free PMC article. No abstract available.
Abstract
The standard method for identifying active Brown Adipose Tissue (BAT) is [18F]-Fluorodeoxyglucose ([18F]-FDG) PET/CT imaging, which is costly and exposes patients to radiation, making it impractical for population studies. These issues can be addressed with computational methods that predict [18F]-FDG uptake by BAT from CT; earlier population studies pave the way for developing such methods by showing some correlation between the Hounsfield Unit (HU) of BAT in CT and the corresponding [18F]-FDG uptake in PET. In this study, we propose training convolutional neural networks (CNNs) to predict [18F]-FDG uptake by BAT from unenhanced CT scans in the restricted regions that are likely to contain BAT. Using the Attention U-Net architecture, we perform experiments on datasets from four different cohorts, the largest study to date. We segment BAT regions using predicted [18F]-FDG uptake values, achieving 23% to 40% better accuracy than conventional CT thresholding. Additionally, BAT volumes computed from the segmentations distinguish the subjects with and without active BAT with an AUC of 0.8, compared to 0.6 for CT thresholding. These findings suggest CNNs can facilitate large-scale imaging studies more efficiently and cost-effectively using only CT.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures
References
-
- Grarup, N., Sandholt, C. H., Hansen, T. & Pedersen, O. Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond. Diabetologia57, 1528–1541 (2014). - PubMed
-
- Sheu, W. H.-H., Brunell, S. C. & Blase, E. Efficacy and tolerability of exenatide twice daily and exenatide once weekly in asian versus white patients with type 2 diabetes mellitus: a pooled analysis. Diab. Res. Clin. Pract.114, 160–172 (2016). - PubMed
-
- Gupta, A. K. et al. Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ascot trial. Am. J. Hypertens.23, 1023–1030 (2010). - PubMed
-
- Dourish, P. What we talk about when we talk about context. Personal. Ubiquitous Comput.8, 19–30 (2004).
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
